Last update 01 Nov 2024

ALLO-ASC-DFU(Anterogen)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms-
Target-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication
Diabetic foot ulcer
Inactive Indication
BurnsEpidermolysis BullosaGlomerulonephritis, IGA
Originator Organization
Anterogen Co., Ltd.Anterogen Co., Ltd.
Active Organization
Anterogen Co., Ltd.Anterogen Co., Ltd.
Inactive Organization
Ishin Pharmaceutical Co. Ltd.
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

14
Clinical Trials associated with ALLO-ASC-DFU(Anterogen)
NCT06141811 / RecruitingNot Applicable
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial
NCT04569409 / RecruitingPhase 3
Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers: A Randomized, Comparator-controlled, Double-blind, Parallel-group, Multi-center Study
NCT04590703 / CompletedNot Applicable
A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 3 Clinical Trial of ALLO-ASC-DFU-301
100 Clinical Results associated with ALLO-ASC-DFU(Anterogen)
Login to view more data
100 Translational Medicine associated with ALLO-ASC-DFU(Anterogen)
Login to view more data
100 Patents (Medical) associated with ALLO-ASC-DFU(Anterogen)
Login to view more data
100 Deals associated with ALLO-ASC-DFU(Anterogen)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic foot ulcerPhase 3
KR
Anterogen Co., Ltd.Anterogen Co., Ltd.
27 Jun 2018
Epidermolysis BullosaDiscovery
JP
Ishin Pharmaceutical Co. Ltd.
01 Mar 2021
BurnsDiscovery
KR
Anterogen Co., Ltd.Anterogen Co., Ltd.
23 Dec 2015
Glomerulonephritis, IGADiscovery
KR
Anterogen Co., Ltd.Anterogen Co., Ltd.
28 Jun 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free